{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013285","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.577198+00:00","generated_at":"2026-05-20T02:43:29.130119+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Propanc Biopharma issues $60,000 promissory note to accredited investor","bullets":["Principal amount $60,000; purchase price $50,000 (implicit $10,000 discount).","Maturity July 15, 2025; interest at 10% per annum.","Repayment at 100% of principal if on/before July 7, 2025; 120% if after through Aug 7, 2025.","Proceeds for general working capital; note issued under Section 4(a)(2) private placement."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013285","json":"https://secwatch.observer/filing/0001641172-25-013285.json","markdown":"https://secwatch.observer/filing/0001641172-25-013285.md","text":"https://secwatch.observer/filing/0001641172-25-013285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225013285/0001641172-25-013285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225013285/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:43:29.130119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3254f97262e4e4e9358f428af45bf4b37fb4cf71","claim":"Propanc Biopharma, Inc. incurred loan of $60,000 with an accredited investor at ten percent (10%) per annum maturing July 15, 2025.","evidence_excerpt":"Effective June 2, 2025, Propanc Biopharma, Inc. (the “Company”) issued a Promissory Note to an accredited investor (the “Investor”) in the aggregate principal amount of $60,000 (the “Note”), for a purchase price of $50,000.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225013285/0001641172-25-013285-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$60,000"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Rate","value":"ten percent (10%) per annum"},{"label":"Maturity","value":"July 15, 2025"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}